Higher levels of SII and SIRI in STEMI patients post-PCI were associated with increased risk of all-cause mortality and major adverse cardiovascular events after one year.
Do higher levels of systemic immune-inflammation index (SII) and systemic inflammation response index (SIRI) predict all-cause mortality and MACEs in patients with STEMI following urgent PCI?
Absolute Event Rate: 0% vs 0%
BACKGROUND: Although systemic immune-inflammation index (SII) and the systemic inflammation response index (SIRI) have garnered attention as novel inflammatory response markers in various clinical contexts, their application in patients with ST-segment elevation myocardial infarction (STEMI) following percutaneous coronary intervention (PCI) remains unclear. This study aims to fill this gap by investigating and validating the relationships between SII, SIRI, and the risks for all-cause mortality and major adverse cardiovascular events (MACEs) in this specific patient population. METHODS: 1222 participants diagnosed with STEMI and who underwent urgent PCI were included in the study. Cox proportional hazards regression analyses were employed to analyze the association between log RESULTS: After a 1-year follow-up, 106 experienced all-cause mortality, and 163 experienced MACEs. Higher levels of log CONCLUSIONS: Log
Yan et al. (Mon,) reported a other. Higher levels of SII and SIRI in STEMI patients post-PCI were associated with increased risk of all-cause mortality and major adverse cardiovascular events after one year.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: